Clinical Trials Sponsored by Intec Pharma Ltd.

Total 1212 results

Follicle Pharma Ltd

Recruiting

Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia

Androgenic Alopecia

Israel
Kamari Pharma Ltd

Recruiting

Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases

KPPP1 | Pachyonychia, Congenital

Israel
Artios Pharma Ltd

Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Ovarian Cancer | Fallopian Tube Cancer | Metastatic Cancer | Advanced Cancer | Primary Peritoneal Cancer

United States, Spain, United Kingdom, France
Small Pharma Ltd

Completed

SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients

Major Depressive Disorder

United Kingdom
Levation Pharma, Ltd.

Completed

LEV102 Topical Gel in Acquired Blepharoptosis

Acquired Blepharoptosis

United States
Immunity Pharma Ltd.

Suspended

A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV

Amyotrophic Lateral Sclerosis (ALS)

Israel
UroGen Pharma Ltd.

Active, not recruiting

A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (ENVISION)

Bladder Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma

United States, Spain, Lithuania, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Austria
Small Pharma Ltd

Completed

SPL026 With or Without SSRIs in Participants With MDD

Major Depressive Disorder

United Kingdom
UroGen Pharma Ltd.

Terminated

A Phase 3 Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (ATLAS)

Bladder Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma

United States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
Reneo Pharma Ltd

Completed

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

Fatty Acid Oxidation Disorders

United States, France, Spain
Lutris Pharma Ltd.

Completed

LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients

Radiation Dermatitis

United States
Aurobindo Pharma Ltd

Completed

Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH (QVR)

Bronchial Asthma

India
Regenera Pharma Ltd

Terminated

Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Nonarteritic Anterior Ischemic Optic Neuropathy

United States
UroGen Pharma Ltd.

Withdrawn

Efficacy and Safety of UGN-101 in Recurrent Patients (Retreatment)

Carcinoma | Transitional Cell Carcinoma | Transitional Cell Cancer of the Renal Pelvis and Ureter

Israel, United States
Regenera Pharma Ltd

Completed

Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION).

Non-arteritic Ischemic Optic Neuropathy | Optic Nerve Injuries

Israel
Bioblast Pharma Ltd.

Withdrawn

Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose

Oculopharyngeal Muscular Dystrophy

Canada
Acacia Pharma Ltd

Completed

US Phase III Study of APD421 in PONV

PONV

United States
Acacia Pharma Ltd

Completed

Study of APD421 as PONV Treatment (Prior Prophylaxis)

Postoperative Nausea and Vomiting

United States, Germany, France
Naveh Pharma LTD

Completed

The Study of Efficacy and Safety of a 60-day Use of the Magnox Comfort Compared to the Placebo in Subjects With NLC

Nocturnal Leg Cramps

Ukraine
Acacia Pharma Ltd

Completed

Thorough QT Study of Intravenous Amisulpride

Healthy
RDD Pharma Ltd

Completed

The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure

Chronic Anal Fissure

Bulgaria, Moldova, Republic of, Poland, Romania
Acacia Pharma Ltd

Completed

Study of APD421 With and Without Ondansetron

Postoperative Nausea and Vomiting

United Kingdom
Topivert Pharma Ltd

Completed

Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis (TOP2)

Ulcerative Colitis

Poland, Ukraine, United Kingdom, Bulgaria, Hungary, Lithuania, Czechia, Latvia
UroGen Pharma Ltd.

Withdrawn

Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2") (INTIMO2)

Overactive Bladder

Israel
Regenera Pharma Ltd

Withdrawn

Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn

Partial Thickness Burn | Second Degree Burn Less Than 5%TBSA

Israel
UroGen Pharma Ltd.

Completed

Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients

Neoplasms | Urologic Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms

India
Spirig Pharma Ltd.

Completed

Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)

Cutaneous Lupus Erythematosus

Germany
RDD Pharma Ltd

Terminated

An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing

Anal Fissure

Israel
UroGen Pharma Ltd.

Withdrawn

A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) (NMIBC TURBT HG)

Non Muscle Invasive Bladder Cancer

Israel
Spirig Pharma Ltd.

Completed

Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis

Skin Alterations Associated With Atopic Dermatitis

Germany
RDD Pharma Ltd

Withdrawn

A Double Blinded Study to Examine the Effect of Coated Suppositories on Fecal Incontinence in Patients With Spinal Cord Injury

Fecal Incontinenece

Israel
Tiltan Pharma Ltd.

Unknown

Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC) (TLH-202)

Metastatic Castration Resistant Prostate Cancer (CRPC)

Israel
Acacia Pharma Ltd

Completed

Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)

Postoperative Nausea and Vomiting

United States, Switzerland, Germany, France
RDD Pharma Ltd

Completed

Study to Examine the Effect of Coated Phenylephrine Suppositories on Anal Pressure in Healthy Subjects

Incontinence

Israel
RDD Pharma Ltd

Completed

An Open Label Study to Examine the Effect of Coated Nifedipine Suppositories on Anal Pressure in Healthy Subjects

Anal Resting Pressure

Israel
Xention Ltd
Ario Pharma Ltd

Completed

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Xention Ltd
Ario Pharma Ltd

Completed

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough

Chronic Idiopathic Cough

United Kingdom, Ireland
UroGen Pharma Ltd.
Tanner Pharma Group

Available

Named Patient Program for Mitomycin for Pyelocalyceal Solution

Urothelial Carcinoma | Urothelial Cancer of Renal Pelvis | Urothelial Carcinoma Ureter | Urothelial Carcinoma Recurrent | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma Ureter Recurrent
Guangzhou JOYO Pharma Co., Ltd
Chengdu JOYO pharma Co., Ltd.

Not yet recruiting

A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
Acacia Pharma Ltd
Paion UK Ltd.

Active, not recruiting

Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

Pediatric ALL

United States, Denmark
Chengdu JOYO pharma Co., Ltd.
Guangzhou JOYO Pharma Co., Ltd

Not yet recruiting

A Clinical Trial Evaluating JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors

Advanced Solid Tumors
Luye Pharma Group Ltd.

Not yet recruiting

To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets

Major Depressive Disorder
Luye Pharma Group Ltd.

Not yet recruiting

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Negative Symptoms of Schizophrenia | Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis | Hallucinations and Delusions Associated With Parkinson Disease Psychosis

China
Luye Pharma Group Ltd.

Recruiting

First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.

Advanced Solid Tumor

China
Luye Pharma Group Ltd.

Recruiting

A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.

Generalized Anxiety Disorder

China
Shanton Pharma Co., Ltd.

Recruiting

Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.

Gout

United States, Puerto Rico
ImmVira Pharma Co. Ltd

Recruiting

A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Lymphoma | Lung Cancer | Advanced Solid Tumor | Liver Cancer | Mesothelioma of Pleura

China
Luye Pharma Group Ltd.

Recruiting

Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors

Bone Metastases From Solid Tumors

China
ImmVira Pharma Co. Ltd

Recruiting

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Melanoma | Sarcoma | NSCLC | Solid Tumor | HNSCC | Squamous Cell Carcinoma

United States, Australia

Clinical Trials Sponsored by Intec Pharma Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations